Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
PaperCitations, authors & open-access status
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 735 citations, 2012 year and closed oa status.
735
Citations
2012
Year
closed
OA Status